The title of the five-year project is ‘Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice’.

PLAYTIME: A serious game for people suffering from dementia.

In 2017 the Physical Activity Working Group is established, as part of the COPD Biomarker Qualification Consortium (CBQC). The Biomarkers Consortium is created to help qualify new tools to support development of better treatment and medicines that will help improve the lives of those with COPD.

The DynaPort MoveMonitor was used in a Phase IV pharmaceutical trial to search for the efficacy of a COPD drug.

The DynaPort MoveMonitor was used in a Phase IIb pharmaceutical trial to evaluate the efficacy and safety of a medication for the treatment of patients with COPD.